TATakeda TAK · NYSE
$20.92 +4.55% (+$0.91)
- Market cap
- ¥10.1T
- Enterprise value
- ¥14.5T
- P/E
- 55.3x
- Forward P/E
- 50.7x
- PEG
- 0.6x
- P/S
- 2.2x
- P/FCF
- 18.0x
- EV/EBITDA
- 11.5x
- ROIC
- 2.5%
- Gross margin
- 59.0%
- Net margin
- 3.9%
- Dividend yield
- 3.10%
- Payout ratio
- 171.1%
- Net debt/EBITDA
- 3.5x
- Beta
- 0.09
- Free float
- 99.2%
About the company
Takeda Pharmaceutical Company Ltd. (Takeda) is a Japanese pharmaceutical company headquartered in Tokyo. Takeda is one of the largest pharmaceutical companies in the world and has a global presence. The company focuses on research, development, and manufacturing of pharmaceutical products in various therapeutic areas, including oncology, gastroenterology, neuroscience, and more. Takeda is committed to innovation and improving the health of people worldwide. Takeda Pharmaceutical Company Ltd. shares may be suitable for investors seeking opportunities in the pharmaceutical sector and monitoring developments in drug research and disease treatment.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Julie So-Young Kim
Employees
47,029
Headquarters
Tokyo
Valuation
Is today's price reasonable?
- What to watch: You pay 55.3 JPY for 1 JPY of yearly profit, a lot for its sector.
Growth and estimates
Is it growing, and what comes next?
- What to watch: Earnings per share fell by 14% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 JPY of revenue, 12 JPY is left as free cash.
- What speaks for it: It has been profitable 6 years in a row.
Financial health
Can it carry its debt?
- What to watch: Operating profit covers the interest on its debt only 1.9 times.
Capital and dividends
What does the company do with the money it earns?
- What to watch: It pays out more in dividends than it earns: 171% of profit.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number